Skip to main content
OpenTrials
Completed

NCT Number: NCT03013907

Emotional Awareness and SElf-regulation for Depression in Patients With Hypertension (EASE) Study

The purpose of this study is to adapt and then evaluate the feasibility, acceptability, and efficacy of a telephone-based intervention (UPLIFT: Using Practice and Learning to Increase Favorable Thoughts) for individuals with elevated depressive symptoms and hypertension. UPLIFT is a group-based intervention that is delivered over 8 weekly sessions for 1 hour/week by phone.

Aim 1 of this study is to adapt UPLIFT using qualitative focus groups and individual interviews and to test the adapted UPLIFT program in a single-arm design. Aim 2 of this study is a randomized controlled trial (RCT) that will compare the effects of the adapted UPLIFT program to usual care (UC) and to test mediators and moderators of the effects of UPLIFT.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Cardiovascular Diseases Vascular Diseases

Age range

21 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

New York University Medical Center

New York, 10016, United States

About this study

Once 16 participants are enrolled (to form 2 groups of 8 patients each), an independent study staff member will determine participants' group assignments. The randomization sequence will be created a priori by Dr. Keith Goldfeld (biostatistician) by using a computer-generated list of random numbers with stratification by antidepressant medication use and baseline levels of depressive symptoms (PHQ scores <10 and ≥10).

UPLIFT: Eligible participants will complete 8 weekly group sessions by phone. The intervention builds cognitive-behavioral and mindfulness skills to help reduce depressive symptoms. Each hour-long weekly session consists of: check-in, instruction, skill building, discussion, and a home-based practice assignment.

Usual care: Subjects randomized to UC will be advised to seek help from their primary care physician (PCP) or other sources as they normally would if they encountered symptomatic deterioration or other difficulties over the course of the study. All treatments received over the course of the study for the UC group and outside of the study (for the intervention group) will be assessed at each time point.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of hypertension based on the criteria in the ICD-9/-10
  • Mild to moderate depressive symptoms (PHQ-9 ≥ 5)
  • English-speaking
  • If taking depression medications, medications must stable for the past 6 weeks (no change to type or dose)
  • Willing to provide informed consent, be audio-recorded, and comply with all other aspects of protocol

Exclusion criteria

  • Moderate to severe depressive symptoms (PHQ-9 ≥ 15)
  • Current substance abuse
  • Current eating disorder
  • Self-harm within the past 3 months
  • Current obsessive-compulsive disorder
  • Current anxiety disorder (e.g., PTSD, panic disorder)
  • Active suicidal ideation
  • History of or current diagnosis of psychosis
  • Significant cognitive impairment (mini mental state examination score ≤ 20)
  • History of previous training in mindfulness
  • History of more than 8 sessions of cognitive behavioral therapy
  • Counseling more frequently than once per month

Treatment and study plan

UPLIFT

Behavioral

Session 1: Introduction to UPLIFT/Noticing Thoughts Session 2: Checking and Changing Thoughts Session 3: Coping & Relaxing Session 4: Attention & Mindfulness Session 5: The Present as a Calm Place Session 6: Thoughts as Changeable, Thoughts as Not Fixed Session 7: Focus on Pleasure & the Importance of Reinforcement Session 8: Preventing Lapses and Giving Thanks

Usual Care

Behavioral

Subjects randomized to UC will be advised to seek help from their primary care physician (PCP) or other sources as they normally would if they encountered symptomatic deterioration or other difficulties over the course of the study

Primary outcomes

  1. Feasibility measured by the number of weekly sessions attended

    Time frame: 6 Months

    Determined by the number of weekly sessions attended and number of days of home-based practice completed each week

  2. Acceptability

    Time frame: 6 Months

    8-item Client Satisfaction Questionnaire (CSQ-8)

  3. PHQ-9

    Time frame: 6 Months

    validated measure of depressive symptoms. Items rate symptom severity during the prior 2 weeks based on DSM-IV diagnostic criteria for major depression. Scores range from 0-27; scores of 5, 10, 15, and 20 represent mild, moderate, moderately severe, and severe depression, respectively. The PHQ-9 will be completed at screening and at all study visits (continuous scores).

  4. Quick Inventory of Depressive Symptomatology (QIDS-SR 16)

    Time frame: 6 Months

    Standardized depression instrument that has treatment sensitivity advantages over the PHQ-9 and will be administered at pre- and post-treatment. Total scores on the QIDS-SR16 range from 0 to 27 and reflect depression severity across 9 domains of the DSM-IV MDD criteria: depressed mood, loss of interest or pleasure, concentration/decision making, self-outlook, suicidal ideation, energy/fatigability, sleep, weight/appetite change, and psychomotor changes.

Sponsors and collaborators

Lead sponsor

NYU Langone Health

Other

Registry information

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Jan 9, 2017
Registry last updated
Nov 13, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.